Adult Gliosarcoma — Trials

Adult Gliosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

81 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 25%
Top sponsor: James Markert, MD
Termination share: 45.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (21)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00268385	Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas	active not recruiting	Phase 1	83	National Cancer Institute (NCI)NIH	1	Aug 20, 2026	clinicaltrials
NCT06614855	A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma	active not recruiting	Phase 1	12	James Markert, MDOTHER	1	Aug 13, 2026	clinicaltrials